durapatite has been researched along with imatinib mesylate in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marycz, K; Serwotka-Suszczak, A; Sobierajska, P; Szymanski, D; Wiglusz, RJ | 1 |
1 other study(ies) available for durapatite and imatinib mesylate
| Article | Year |
|---|---|
Nanohydroxyapatite-Mediated Imatinib Delivery for Specific Anticancer Applications.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Durapatite; Dynamic Light Scattering; Humans; Imatinib Mesylate; Microscopy, Atomic Force; Spectrometry, X-Ray Emission; Spectroscopy, Fourier Transform Infrared | 2020 |